Review article: the endocannabinoid system in liver disease, a potential therapeutic target (Q38194626)

30 August 2017

1 reference

title

Review article: the endocannabinoid system in liver disease, a potential therapeutic target (English)

1 reference

30 August 2017

main subject

endocannabinoid system

0 references

1 reference

P P Basu

1

1 reference

30 August 2017

M M Aloysius

series ordinal

2

1 reference

30 August 2017

N J Shah

series ordinal

3

1 reference

30 August 2017

R S Brown

series ordinal

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

24 February 2014

1 reference

Alimentary Pharmacology & Therapeutics

30 August 2017

published in

1 reference

30 August 2017

volume

39

1 reference

30 August 2017

issue

8

1 reference

30 August 2017

page(s)

790-801

1 reference

Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver

30 August 2017

cites work

1 reference

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

21 January 2018

1 reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

21 January 2018

1 reference

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

Peripheral cannabinoid receptor, CB2, regulates bone mass

21 January 2018

1 reference

Presence of functional cannabinoid receptors in human endocrine pancreas

21 January 2018

1 reference

Identification and functional characterization of brainstem cannabinoid CB2 receptors

21 January 2018

1 reference

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

21 January 2018

1 reference

Treatment options for nonalcoholic Fatty liver disease

21 January 2018

1 reference

Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis

21 January 2018

1 reference

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

21 January 2018

1 reference

Multiple pathways involved in the biosynthesis of anandamide

21 January 2018

1 reference

A biosynthetic pathway for anandamide

21 January 2018

1 reference

Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain

21 January 2018

1 reference

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

21 January 2018

1 reference

Role of endogenous cannabinoids in synaptic signaling

21 January 2018

1 reference

Anandamide and vanilloid TRPV1 receptors

21 January 2018

1 reference

The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil

21 January 2018

1 reference

Molecular characterization of human and mouse fatty acid amide hydrolases

21 January 2018

1 reference

Anandamide hydrolysis by human cells in culture and brain

21 January 2018

1 reference

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

Brain monoglyceride lipase participating in endocannabinoid inactivation

21 January 2018

1 reference

The emerging role of the endocannabinoid system in cardiovascular disease

21 January 2018

1 reference

Rimonabant: From RIO to Ban.

21 January 2018

1 reference

Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

21 January 2018

1 reference

Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey

21 January 2018

1 reference

Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study

21 January 2018

1 reference

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans

21 January 2018

1 reference

Activation of the peripheral endocannabinoid system in human obesity

21 January 2018

1 reference

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

21 January 2018

1 reference

Causes and metabolic consequences of Fatty liver

21 January 2018

1 reference

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial

21 January 2018

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes

21 January 2018

1 reference

Anandamide induces necrosis in primary hepatic stellate cells

21 January 2018

1 reference

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

21 January 2018

1 reference

Non-invasive assessment of liver fibrosis: it is time for laboratory medicine

21 January 2018

1 reference

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

21 January 2018

1 reference

Hemodynamic alterations in cirrhosis and portal hypertension

21 January 2018

1 reference

The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension

21 January 2018

1 reference

Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor

21 January 2018

1 reference

Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells

21 January 2018

1 reference

Elevated endotoxin levels in non-alcoholic fatty liver disease

21 January 2018

1 reference

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

21 January 2018

1 reference

Role of cannabinoids in chronic liver diseases

21 January 2018

1 reference

Interactions of the heart and the liver.

21 January 2018

1 reference

Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.

21 January 2018

1 reference

Review article: alcoholic liver disease--pathophysiological aspects and risk factors.

21 January 2018

1 reference

Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances

21 January 2018

1 reference

The effect of ethanol on fatty acid metabolism; stimulation of hepatic fatty acid synthesis in vitro

21 January 2018

1 reference

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver

21 January 2018

1 reference

STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

21 January 2018

1 reference

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts

21 January 2018

1 reference

Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury

21 January 2018

1 reference

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

21 January 2018

1 reference

Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

21 January 2018

1 reference

Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice

21 January 2018

1 reference

Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice

21 January 2018

1 reference

Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase

21 January 2018

1 reference

Preliminary observation with dronabinol in patients with intractable pruritus secondary to cholestatic liver disease

21 January 2018

1 reference

Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation

21 January 2018

1 reference

Clinical implications of novel aspects of biliary pathophysiology

21 January 2018

1 reference

Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.

21 January 2018

1 reference

Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity

21 January 2018

1 reference

Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells

21 January 2018

1 reference

Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology

21 January 2018

1 reference

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12673

1 reference

30 August 2017

1 reference